miRNAs and isomiRs: Serum-Based Biomarkers for the Development of Intellectual Disability and Autism Spectrum Disorder in Tuberous Sclerosis Complex

• Published in: Biomedicines Vol. 10; no. 8; p. 1838
• Main Authors: Scheper, Mirte, Romagnolo, Alessia, Besharat, Zein Mersini, Iyer, Anand M, Moavero, Romina, Hertzberg, Christoph, Weschke, Bernhard, Riney, Kate, Feucht, Martha, Scholl, Theresa, Petrak, Borivoj, Maulisova, Alice, Nabbout, Rima, Jansen, Anna C, Jansen, Floor E, Lagae, Lieven, Urbanska, Malgorzata, Ferretti, Elisabetta, Tempes, Aleksandra, Blazejczyk, Magdalena, Jaworski, Jacek, Kwiatkowski, David J, Jozwiak, Sergiusz, Kotulska, Katarzyna, Sadowski, Krzysztof, Borkowska, Julita, Curatolo, Paolo, Mills, James D, Aronica, Eleonora
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 29-07-2022; MDPI
• Subjects: Age; Autism; autism spectrum disorder; Bioinformatics; Biomarkers; Caregivers; Comorbidity; Convulsions & seizures; Epilepsy; Genes; Genetic aspects; Genetic disorders; Health aspects; Intellectual disabilities; intellectual disability; Mental disorders; MicroRNA; MicroRNAs; miRNA; Mutation; Non-coding RNA; Patients; Proteins; Risk assessment; Sclerosis; Sequence analysis; serum; Tuberous sclerosis; tuberous sclerosis complex; Taiwan; United States > US
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines10081838

Tuberous sclerosis complex (TSC) is a rare multi-system genetic disorder characterized by a high incidence of epilepsy and neuropsychiatric manifestations known as tuberous-sclerosis-associated neuropsychiatric disorders (TANDs), including autism spectrum disorder (ASD) and intellectual disability (ID). MicroRNAs (miRNAs) are small regulatory non-coding RNAs that regulate the expression of more than 60% of all protein-coding genes in humans and have been reported to be dysregulated in several diseases, including TSC. In the current study, RNA sequencing analysis was performed to define the miRNA and isoform (isomiR) expression patterns in serum. A Receiver Operating Characteristic (ROC) curve analysis was used to identify circulating molecular biomarkers, miRNAs, and isomiRs, able to discriminate the development of neuropsychiatric comorbidity, either ASD, ID, or ASD + ID, in patients with TSC. Part of our bioinformatics predictions was verified with RT-qPCR performed on RNA isolated from patients’ serum. Our results support the notion that circulating miRNAs and isomiRs have the potential to aid standard clinical testing in the early risk assessment of ASD and ID development in TSC patients.